World news, news around town, tech update 3
Ad
Wednesday, 28 February 2018
AstraZeneca spins off autoimmune drugs into new biotech company
LONDON (Reuters) - AstraZeneca is spinning off six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune diseases.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment